Literature DB >> 18828998

129/SvJ mice have mutated CD23 and hyper IgE.

Jill W Ford1, Jamie L Sturgill, Daniel H Conrad.   

Abstract

CD23, the low affinity IgE receptor, is hypothesized to function as a negative regulator of IgE production. Upon discovering reduced CD23 surface levels in 129/SvJ inbred mice, we sought to further investigate 129/SvJ CD23 and to examine its influence on IgE levels. Five amino acid substitutions were found in 129/SvJ CD23. Identical mutations were also observed in CD23 from New Zealand Black and 129P1/ReJ mice. 129/SvJ B cells proliferated more rapidly than those from BALB/c after stimulation with IL-4 and CD40 ligand trimer. However, in vitro IgE levels in supernatants from stimulated 129/SvJ B cells were significantly reduced. Contrary to the in vitro findings, the 129/SvJ CD23 mutations correlated with a hyper IgE phenotype in vivo and 129/SvJ were able to clear Nippostrongylus brasiliensis infection more rapidly than either BALB/c or C57BL/6. Overall, this study further suggests that CD23 is an important regulatory factor for IgE production.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18828998      PMCID: PMC2643045          DOI: 10.1016/j.cellimm.2008.08.003

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  43 in total

1.  Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome.

Authors:  Yoshiyuki Minegishi; Masako Saito; Shigeru Tsuchiya; Ikuya Tsuge; Hidetoshi Takada; Toshiro Hara; Nobuaki Kawamura; Tadashi Ariga; Srdjan Pasic; Oliver Stojkovic; Ayse Metin; Hajime Karasuyama
Journal:  Nature       Date:  2007-08-05       Impact factor: 49.962

2.  Th2 induction by Nippostrongylus secreted antigens in mice deficient in B cells, eosinophils or MHC Class I-related receptors.

Authors:  Martin J Holland; Yvonne M Harcus; Adam Balic; Rick M Maizels
Journal:  Immunol Lett       Date:  2005-01-15       Impact factor: 3.685

3.  Negative regulation of lymphocyte activation by the adaptor protein LAX.

Authors:  Minghua Zhu; Olivia Granillo; Renren Wen; Kaiyong Yang; Xuezhi Dai; Demin Wang; Weiguo Zhang
Journal:  J Immunol       Date:  2005-05-01       Impact factor: 5.422

4.  Hyper IgE in New Zealand black mice due to a dominant-negative CD23 mutation.

Authors:  Graham Lewis; Eleni Rapsomaniki; Tiphaine Bouriez; Tanya Crockford; Helen Ferry; Robert Rigby; Timothy Vyse; Teresa Lambe; Richard Cornall
Journal:  Immunogenetics       Date:  2004-10-19       Impact factor: 2.846

5.  ADAM10 is a principal 'sheddase' of the low-affinity immunoglobulin E receptor CD23.

Authors:  Gisela Weskamp; Jill W Ford; Jamie Sturgill; Steve Martin; Andrew J P Docherty; Steven Swendeman; Neil Broadway; Dieter Hartmann; Paul Saftig; Shelby Umland; Atsuko Sehara-Fujisawa; Roy A Black; Andreas Ludwig; J David Becherer; Daniel H Conrad; Carl P Blobel
Journal:  Nat Immunol       Date:  2006-10-29       Impact factor: 25.606

6.  IL-5 and Rp105 signaling defects in B cells from commonly used 129 mouse substrains.

Authors:  L M Corcoran; D Metcalf
Journal:  J Immunol       Date:  1999-12-01       Impact factor: 5.422

7.  Humoral response suppression observed with CD23 transgenics.

Authors:  M E Payet; E C Woodward; D H Conrad
Journal:  J Immunol       Date:  1999-07-01       Impact factor: 5.422

Review 8.  Hyper-IgE syndromes.

Authors:  Bodo Grimbacher; Steven M Holland; Jennifer M Puck
Journal:  Immunol Rev       Date:  2005-02       Impact factor: 12.988

9.  IL-21 dependent IgE production in human and mouse in vitro culture systems is cell density and cell division dependent and is augmented by IL-10.

Authors:  Timothy H Caven; Anne Shelburne; Jun Sato; Yee Chan-Li; Steve Becker; Daniel H Conrad
Journal:  Cell Immunol       Date:  2006-04-05       Impact factor: 4.868

10.  Natural IgE production in the absence of MHC Class II cognate help.

Authors:  Kathy D McCoy; Nicola L Harris; Philipp Diener; Sarah Hatak; Bernhard Odermatt; Lars Hangartner; Beatrice M Senn; Benjamin J Marsland; Markus B Geuking; Hans Hengartner; Andrew J S Macpherson; Rolf M Zinkernagel
Journal:  Immunity       Date:  2006-03       Impact factor: 31.745

View more
  7 in total

Review 1.  CD23/FcεRII: molecular multi-tasking.

Authors:  M Acharya; G Borland; A L Edkins; L M Maclellan; J Matheson; B W Ozanne; W Cushley
Journal:  Clin Exp Immunol       Date:  2010-10       Impact factor: 4.330

2.  Myeloid-derived suppressor cells enhance IgE-mediated mast cell responses.

Authors:  Johanna K Morales; Sheinei J Saleem; Rebecca K Martin; Bryan L Saunders; Brian O Barnstein; Travis W Faber; Nicholas A Pullen; Elizabeth Motunrayo Kolawole; Keith B Brooks; Sarah K Norton; Jamie Sturgill; Laura Graham; Harry D Bear; Joseph F Urban; Chris S Lantz; Daniel H Conrad; John J Ryan
Journal:  J Leukoc Biol       Date:  2013-12-12       Impact factor: 4.962

3.  IgE-mediated enhancement of CD4+ T cell responses in mice requires antigen presentation by CD11c+ cells and not by B cells.

Authors:  Frida Henningsson; Zhoujie Ding; Joakim S Dahlin; Marius Linkevicius; Fredrik Carlsson; Kjell-Olov Grönvik; Jenny Hallgren; Birgitta Heyman
Journal:  PLoS One       Date:  2011-07-06       Impact factor: 3.240

4.  Structural basis for selective inhibition of immunoglobulin E-receptor interactions by an anti-IgE antibody.

Authors:  Jiun-Bo Chen; Faruk Ramadani; Marie O Y Pang; Rebecca L Beavil; Mary D Holdom; Alkistis N Mitropoulou; Andrew J Beavil; Hannah J Gould; Tse Wen Chang; Brian J Sutton; James M McDonnell; Anna M Davies
Journal:  Sci Rep       Date:  2018-08-01       Impact factor: 4.996

5.  IgE-neutralizing UB-221 mAb, distinct from omalizumab and ligelizumab, exhibits CD23-mediated IgE downregulation and relieves urticaria symptoms.

Authors:  Be-Sheng Kuo; Chao-Hung Li; Jiun-Bo Chen; Yu-Yu Shiung; Chia-Yu Chu; Chih-Hung Lee; Yaw-Jen Liu; Je-Hung Kuo; Cindy Hsu; Hsiao-Wen Su; Ywan-Feng Li; Annie Lai; Yueh-Feng Ho; Yi-Ning Cheng; Hong-Xuan Huang; Meng-Chung Lung; Ming-Syue Wu; Fu-Hong Yang; Chen-Han Lin; William Tseng; Jasper Yang; Chia-Yin Lin; Pei-Hua Tsai; Heng-Kwei Chang; Yi-Jen Wang; Techeng Chen; Shugene Lynn; Mei-June Liao; Chang Yi Wang
Journal:  J Clin Invest       Date:  2022-08-01       Impact factor: 19.456

6.  Uncoupling of natural IgE production and CD23 surface expression levels.

Authors:  Weicheng Ren; Kristina Lagerstedt; Ola Grimsholm; Anna Stern; Jia-Bin Sun; Yu Fang; Zou Xiang; Inga-Lill Mårtensson
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

7.  Using the emerging Collaborative Cross to probe the immune system.

Authors:  J Phillippi; Y Xie; D R Miller; T A Bell; Z Zhang; A B Lenarcic; D L Aylor; S H Krovi; D W Threadgill; F Pardo-Manuel de Villena; W Wang; W Valdar; J A Frelinger
Journal:  Genes Immun       Date:  2013-11-07       Impact factor: 2.676

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.